Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gliknik Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10933
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against important epitopes within the cancer protein MAGE-A3. Gliknik designs recombinant GL-2045 to mimic the structure and efficacy of the very small and variable portion of the pooled human blood product IVIG, which is an active fraction in treating autoimmune disorders. The company partners with pharmaceutical industries. Gliknik is headquartered in Baltimore, Maryland, the US.

Gliknik Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Licensing Agreements 14
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc – Key Competitors 15
Gliknik Inc – Key Employees 16
Gliknik Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Gliknik Inc, Pharmaceuticals & Healthcare, Key Facts 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc, Key Competitors 15
Gliknik Inc, Key Employees 16

List of Figures
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ExpressJet Airlines, Inc:企業の戦略・SWOT・財務情報
    ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report Summary ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Laboratorios LETI SL:企業の戦略的SWOT分析
    Laboratorios LETI SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Livzon Pharmaceutical Group Inc (000513):製薬・医療:M&Aディール及び事業提携情報
    Summary Livzon Pharmaceutical Group Inc (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and inte …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healt …
  • Lansforsakringar AB:企業の戦略・SWOT・財務分析
    Lansforsakringar AB - Strategy, SWOT and Corporate Finance Report Summary Lansforsakringar AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PTC KAMAZ:企業のM&A・事業提携・投資動向
    PTC KAMAZ - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC KAMAZ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Inc is a specialty pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product portfolio includ …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Morphogenesis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphogenesis Inc (Morphogenesis) is a novel cell and gene therapies developer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibody cell separation device, morphogenesis’ …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務分析
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • United Bank Of India
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Delek Group Ltd:戦略・SWOT・企業財務分析
    Delek Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Delek Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chevron Corporation (CVX):電力:M&Aディール及び事業提携情報
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports c …
  • AXIS Capital Holdings Limited:戦略・SWOT・企業財務分析
    AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆